VERACYTE INC (VCYT) Stock Fundamental Analysis
NASDAQ:VCYT • US92337F1075
35.77 USD
+0.62 (+1.76%)
At close: Feb 13, 2026
35.77 USD
0 (0%)
After Hours: 2/13/2026, 8:00:01 PM
VCYT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 522 industry peers in the Biotechnology industry. While VCYT has a great health rating, its profitability is only average at the moment. VCYT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes VCYT very considerable for growth investing!
1. Profitability
1.1 Basic Checks
- VCYT had positive earnings in the past year.
- In the past year VCYT had a positive cash flow from operations.
- In the past 5 years VCYT reported 4 times negative net income.
- The reported operating cash flow has been mixed in the past 5 years: VCYT reported negative operating cash flow in multiple years.
1.2 Ratios
- The Return On Assets of VCYT (2.22%) is better than 89.10% of its industry peers.
- Looking at the Return On Equity, with a value of 2.41%, VCYT belongs to the top of the industry, outperforming 90.06% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 2.93%, VCYT belongs to the top of the industry, outperforming 90.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROIC | 2.93% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- VCYT's Profit Margin of 6.12% is amongst the best of the industry. VCYT outperforms 89.87% of its industry peers.
- VCYT has a Operating Margin of 9.70%. This is amongst the best in the industry. VCYT outperforms 91.59% of its industry peers.
- VCYT's Gross Margin of 68.53% is amongst the best of the industry. VCYT outperforms 81.07% of its industry peers.
- VCYT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VCYT is destroying value.
- The number of shares outstanding for VCYT has been increased compared to 1 year ago.
- Compared to 5 years ago, VCYT has more shares outstanding
- There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 15.79 indicates that VCYT is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 15.79, VCYT belongs to the top of the industry, outperforming 87.57% of the companies in the same industry.
- There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 15.79 |
ROIC/WACC0.24
WACC12.25%
2.3 Liquidity
- VCYT has a Current Ratio of 6.23. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
- VCYT has a better Current ratio (6.23) than 63.86% of its industry peers.
- VCYT has a Quick Ratio of 5.94. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
- VCYT has a Quick ratio of 5.94. This is in the better half of the industry: VCYT outperforms 63.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 353.33% over the past year.
- The Revenue has grown by 16.41% in the past year. This is quite good.
- Measured over the past years, VCYT shows a very strong growth in Revenue. The Revenue has been growing by 29.93% on average per year.
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
3.2 Future
- The Earnings Per Share is expected to grow by 45.23% on average over the next years. This is a very strong growth
- Based on estimates for the next years, VCYT will show a quite strong growth in Revenue. The Revenue will grow by 11.85% on average per year.
EPS Next Y78.93%
EPS Next 2Y94.08%
EPS Next 3Y63.11%
EPS Next 5Y45.23%
Revenue Next Year15.05%
Revenue Next 2Y13.16%
Revenue Next 3Y12.77%
Revenue Next 5Y11.85%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 94.13, the valuation of VCYT can be described as expensive.
- VCYT's Price/Earnings ratio is rather cheap when compared to the industry. VCYT is cheaper than 89.48% of the companies in the same industry.
- VCYT is valuated expensively when we compare the Price/Earnings ratio to 26.68, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 31.65 indicates a quite expensive valuation of VCYT.
- Based on the Price/Forward Earnings ratio, VCYT is valued cheaply inside the industry as 91.59% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, VCYT is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 94.13 | ||
| Fwd PE | 31.65 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 91.78% of the companies listed in the same industry.
- VCYT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VCYT is cheaper than 93.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.86 | ||
| EV/EBITDA | 34.37 |
4.3 Compensation for Growth
- VCYT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- VCYT has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as VCYT's earnings are expected to grow with 63.11% in the coming years.
PEG (NY)1.19
PEG (5Y)N/A
EPS Next 2Y94.08%
EPS Next 3Y63.11%
5. Dividend
5.1 Amount
- VCYT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
35.77
+0.62 (+1.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners114.83%
Inst Owner Change-87.66%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap2.83B
Revenue(TTM)495.14M
Net Income(TTM)30.31M
Analysts82.11
Price Target49.7 (38.94%)
Short Float %6.58%
Short Ratio6.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0.75%
PT rev (3m)15.74%
EPS NQ rev (1m)7.5%
EPS NQ rev (3m)16.66%
EPS NY rev (1m)1.2%
EPS NY rev (3m)34.36%
Revenue NQ rev (1m)0.94%
Revenue NQ rev (3m)1.6%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)1.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 94.13 | ||
| Fwd PE | 31.65 | ||
| P/S | 5.71 | ||
| P/FCF | 28.86 | ||
| P/OCF | 26.25 | ||
| P/B | 2.25 | ||
| P/tB | 7.1 | ||
| EV/EBITDA | 34.37 |
EPS(TTM)0.38
EY1.06%
EPS(NY)1.13
Fwd EY3.16%
FCF(TTM)1.24
FCFY3.46%
OCF(TTM)1.36
OCFY3.81%
SpS6.26
BVpS15.91
TBVpS5.04
PEG (NY)1.19
PEG (5Y)N/A
Graham Number11.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROCE | 3.71% | ||
| ROIC | 2.93% | ||
| ROICexc | 4.08% | ||
| ROICexgc | 54.52% | ||
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% | ||
| FCFM | 19.79% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 44.07% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.6% | ||
| Profit Quality | 323.21% | ||
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 | ||
| Altman-Z | 15.79 |
F-Score8
WACC12.25%
ROIC/WACC0.24
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y78.93%
EPS Next 2Y94.08%
EPS Next 3Y63.11%
EPS Next 5Y45.23%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year15.05%
Revenue Next 2Y13.16%
Revenue Next 3Y12.77%
Revenue Next 5Y11.85%
EBIT growth 1Y427.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year320.9%
EBIT Next 3Y74.34%
EBIT Next 5Y46.78%
FCF growth 1Y236.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.39%
OCF growth 3YN/A
OCF growth 5YN/A
VERACYTE INC / VCYT FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 6 / 10 to VCYT.
What is the valuation status of VERACYTE INC (VCYT) stock?
ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
How profitable is VERACYTE INC (VCYT) stock?
VERACYTE INC (VCYT) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for VCYT stock?
The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 94.13 and the Price/Book (PB) ratio is 2.25.
What is the financial health of VERACYTE INC (VCYT) stock?
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.